Contract GS07F355AA
Msab Incorporated · General Services Administration · August 15, 2013
Msab Incorporated was awarded a federal contract by General Services Administration (Federal Acquisition Service) on August 15, 2013 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 61 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 8, 2023. If all options are exercised, the contract could reach $9.13 million.
Contract details
- PIID
- GS07F355AA
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Chemical Analysis Instruments
- First action
- August 15, 2013
- Latest action
- June 8, 2023
Description
FEDERAL SUPPLY SCHEDULE CONTRACT
Modification timeline
-
June 8, 2023Mod PA0046$0
-
May 30, 2023Mod PSA856$0
-
January 25, 2023Mod PSA853$0
-
January 18, 2023Mod PA0044$0
-
August 3, 2022Mod PA0043$0
-
July 18, 2022Mod PA0042$0
-
July 7, 2022Mod PSA847$0
-
June 14, 2022Mod PA0041$0
-
June 14, 2022Mod PA0039$0
-
April 27, 2022Mod PA0037$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Leonardo Us Cyber And Security Solutions, Llc | General Services Administration | February 25, 2026 | $0 |
| Peeled Group Llc | General Services Administration | February 4, 2026 | $0 |
| Premier Biotech, Llc | General Services Administration | January 13, 2026 | $0 |
| Merakai, Llc | General Services Administration | September 9, 2021 | $0 |
| V & A Incorporated | General Services Administration | June 22, 2011 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract GS07F355AA?
Contract GS07F355AA is a federal contract awarded to Msab Incorporated by General Services Administration on August 15, 2013 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 61 times since the base award.
Who won contract GS07F355AA?
Msab Incorporated won contract GS07F355AA from General Services Administration.
How much is contract GS07F355AA worth?
Contract GS07F355AA has obligated $0 to date but carries a potential ceiling of $9.13 million if fully funded and all options are exercised.